Skip to main content
Clinical Trials/NCT00140205
NCT00140205CompletedPhase 1

Pharmacokinetics of Leptin Administration During Fasting

Beth Israel Deaconess Medical Center1 site in 1 country15 target enrollmentStarted: February 2001Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
15
Locations
1
Primary Endpoint
Leptin Pharmacokinetics Parameters - AUC 72-hour Fasting Day 3 Leptin Dose 0.01 mg/kg

Study Overview

Brief Summary

The purpose of this study will be to determine the correct dose of leptin, a natural hormone secreted by the fat cells, to give to people when they are fasting and also to determine whether giving leptin to a person when he or she is fasting will reverse the changes in hormone levels that occur with fasting.

Detailed Description

Leptin is a newly-identified hormone secreted by fat cells under normal conditions that acts in the brain to decrease appetite and increase long term energy usage. Leptin levels usually go down when people are not eating for extended periods of time. Changes in metabolism and certain hormone levels also occur with fasting. By studying the pharmacokinetics of leptin administration, we can evaluate the changes of leptin levels in response to giving different doses of leptin as well as acute changes of other hormones in response to leptin levels. Investigations such as this one have important implications for the future therapeutic use of leptin, including determining the appropriate dose of leptin to use in future studies involving leptin administration.

Comparison: subjects receiving leptin at 3 different doses in the fed state compared to the fasting state

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • healthy men with body mass indices (BMI) <25 kg/m2)
  • overweight otherwise healthy men with BMI > 27 kg/m2
  • healthy lean women with BMI<25 kg/m2
  • overweight otherwise healthy women with BMI > 27 kg/m2

Exclusion Criteria

  • history of any illness that may affect the concentrations of the hormones that will be studied (such as anemia, infectious diseases, renal or hepatic failure, diabetes mellitus, cancer, lymphoma, hypogonadism, malabsorption or malnourishment, hypo or hyperthyroidism, hypercortisolism, alcoholism or drug abuse, eating disorders)
  • on medications known to affect the hormones to be measured in this study (such as glucocorticoids, anti-seizure medications or thyroid hormones)
  • known history of anaphylaxis or anaphylactoid-like reactions or who have a known hypersensitivity to E. Coli derived proteins
  • women who are breast feeding, pregnant, or wanting to become pregnant during the next 6 months

Arms & Interventions

Fed state or fasting state

Experimental

1-day fed studies with administration of r-metHuLeptin at three different doses (0.01 mg/kg, 0.1 mg/kg, 0.3 mg/kg). All subjects participated in 3 studies in the fed condition (Part A) and 3 separate 72-hour fasting studies.

Intervention administered was-r-metreleptin in 3 different doses

Intervention: r-metHuLeptin (Drug)

Outcomes

Primary Outcomes

Leptin Pharmacokinetics Parameters - AUC 72-hour Fasting Day 3 Leptin Dose 0.01 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.01 mg/kg

Leptin Pharmacokinetics Parameters - AUC 24-hour Fed Leptin Dose 0.1 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - AUC 72-hour Fasting Day 3 Leptin Dose 0.1 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 72-hour Fasting Day 3 Leptin Dose 0.01 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.01 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) / TMAX 24-hour Fed Leptin Dose 0.3 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.3 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) DAY 3 / TMAX DAY 3 72-hour Fasting Day 3 Leptin Dose 0.3 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.3 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 72-hour Fasting Day 3 Leptin Dose 0.3 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.3 mg/kg

Leptin Pharmacokinetics Parameters - AUC 24-hour Fed Leptin Dose 0.3 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.3 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) / TMAX 24-hour Fed Leptin Dose 0.01 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.01 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) DAY 3 / TMAX DAY 3 72-hour Fasting Day 3 Leptin Dose 0.01 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.01 mg/kg

Leptin Pharmacokinetic Parameters TIME(T1/2) DAY 3 / TMAX DAY 3 72-hour Fasting Day 3 Leptin Dose 0.1 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.1 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) / TMAX 24-hour Fed Leptin Dose 0.1 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 24-hour Fed Leptin Dose 0.1 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 72-hour Fasting Day 3 Leptin Dose 0.1 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - AUC 72-hour Fasting Day 3 Leptin Dose 0.3 mg/kg

Time Frame: 3 DAY

72-hour fasting Day 3 Leptin dose 0.3 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 24-hour Fed Leptin Dose 0.3 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.3 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 24-hour Fed Leptin Dose 0.01 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.01 mg/kg

Leptin Pharmacokinetics Parameters - AUC 24-hour Fed Leptin Dose 0.01 mg/kg

Time Frame: 1 DAY

24-hour fed Leptin dose 0.01 mg/kg

Secondary Outcomes

  • Cytokine Levels 24h Fed or 72h Fasting for All Different Leptin Doses (0,01-0,1-0,3 mg/kg)(1 DAY or DAY 3)
  • Neuroendocrine Hormone Levels 24h Fed or 72h Fasting for All Different Leptin Doses (0,01-0,1-0,3 mg/kg)(1 DAY or DAY 3)
  • Adipokine Hormone Levels 24h Fed or 72h Fasting for All Different Leptin Doses (0,01-0,1-0,3 mg/kg)(day 3 of fasting and day 1 of fed state)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christos Mantzoros

Professor of Medicine

Beth Israel Deaconess Medical Center

Study Sites (1)

Loading locations...

Similar Trials

Pharmacokinetics of Leptin Administration... | Clinical Trial